Council of the Eurasian Economic Commission considered amendments to the Agreement on Uniform Principles and Rules for Circulation of Medical Devices (Medical Devices and Medical Equipment) from 23 December 2014 regarding prolongation of national registration till 31 December 2022.

One more dispute on the claim of a Russian company, which had been subject to restrictive measures, including those of the European Union and the United States, has reached the Supreme Court.

On 17 November 2021 Russia signed Convention on the Recognition and Enforcement of Foreign Judgements in Civil or Commercial Matters ("the Convention"). Ukraine, Uruguay, Israel, and Costa Rica also signed the Convention.

The State Duma of the Russian Federation approved a bill (Bill) providing amendments to the legislation on the protection of competition in the first reading.

Electronic document management in the area of labour relations is not new and has been actively used by companies for years already.

The Supreme Court provided clarifications on why during the moratorium on bankruptcy, the penalty cannot be paid even in disputes with consumers, in which cases the software update entails the seller's obligation to compensate the cost of the goods and why even a resident of the apartment is considered a consumer.

Ministry of Industry and Trade prepared a draft on amending the Regulations of the Russian Government No. 1289 of 30 November 2015. Under the draft the drugs from the List of Strategically Important Drugs produced in a foreign country shall be rejected to supply by the customer if there is at least one offer to supply a drug produced (all manufacturing stages) exclusively in the territory of the Eurasian Union member states.

On 28 October 2021, the Russian Constitutional Court passed a decision in which it examined Art. 110 para. 1 of the Russian Commercial (Arbitrazh) Procedure Code for compliance with the Constitution and clarified when right holders shall not reimburse legal costs to a defendant if the court reduced the compensation.

During the meeting with foreign companies on 16 September 2021, the Ministry of Economic Development announced that it prepared a draft law on the Register of the pharmaceutically active ingredients protected by patents.

From September 1, 2021, amendments to the Rules for issuing Permits for the Retail Sale of Medicines for Medical Use by remote Means, the Implementation of such sale and the delivery of medicines to Citizens, approved by the Decree of the Government of the Russian Federation dated 31.05.2021 N 827 (hereinafter – the Rules), came into force.